2026-06-29 · older adults, geriatric, BMI, obesity paradox, frailty, weight management · 13 min read

Should I lose weight at 70?

Sometimes yes, often no — and the right answer is almost never the same one a 40-year-old would get. The 2023 AGS / NIA position (Batsis 2023, Journal of the American Geriatrics Society) frames intentional weight loss in adults 65 and older as a function-first decision, not a scale decision. If your BMI is in the high-overweight or obese range, your grip strength and gait speed are still strong, you have weight-driven knee or hip pain or poorly controlled type 2 diabetes, and you are willing to pair the deficit with resistance training and 1.2–1.5 g/kg of protein, then intentional loss is reasonable and the LIFE trial (Villareal 2017, New England Journal of Medicine) showed it improves function. If you are already frail, recently hospitalized, or losing weight unintentionally, the answer is different — that case calls for nutrition support and rehabilitation, not a deficit.

What's the obesity paradox?

It is the repeated finding in older-adult cohorts that the BMI associated with the lowest all-cause mortality shifts upward after age 65 — roughly 25–32 in most analyses, well above the 22–25 'healthy' range used in middle-aged populations. Winter 2014's American Journal of Clinical Nutrition meta-analysis and Flegal 2013's JAMA meta both documented the pattern. The paradox does not mean weight gain is protective. It means BMI alone becomes a weaker predictor of mortality in older adults — function, muscle mass, and frailty become better ones. The practical takeaway: do not use middle-age BMI cut-points to decide whether an 80-year-old needs to lose weight, and do not assume an older adult with a BMI of 28 is in trouble.

Is BMI 27 still 'overweight' for me?

Technically yes by the WHO definition, but the clinical meaning is different at 75 than at 35. In adults over 65 with stable weight, normal grip strength, normal gait speed, and no metabolic disease, a BMI of 27 sits comfortably inside the lowest-mortality band identified in Winter 2014 and Flegal 2013. In that case there is no health gain from chasing a lower number, and a deficit risks costing lean mass and bone you cannot easily replace. If the same BMI of 27 comes with knee pain, poorly controlled diabetes, sleep apnea, or fatty liver, intentional loss of 5–10 percent with resistance training and protein protection is still reasonable per Villareal 2017.

How fast should I lose weight as an older adult?

Slower than you would have at 40. A reasonable target is 0.25 to 0.5 percent of body weight per week — about half the pace usually quoted for middle-aged adults. Heymsfield 2014's Obesity Reviews analysis showed that the share of weight lost as lean mass grows as the deficit gets larger and the trajectory gets steeper. Kortebein 2007's JAMA bedrest experiment showed how quickly older adults shed lean mass when inactive. Slower loss preserves more muscle and bone, leaves more margin to add resistance training and protein, and is easier to maintain. If the goal is a 5–10 percent loss, plan on roughly 6–12 months, not 3.

Should I take a GLP-1 medication in my 70s?

It is reasonable in selected adults — and the evidence base for adults 65 and older is now solid. The 2021 STEP-1 semaglutide trial (Wilding 2021, NEJM) included adults 65 and older and showed comparable weight loss to younger participants. The 2023 SELECT cardiovascular outcomes trial (Lincoff 2023, NEJM) showed reduced major adverse cardiovascular events in adults with established cardiovascular disease and BMI ≥27 — with substantial enrollment of adults over 65. The caveats are real: dose titrate more slowly, watch for gastrointestinal side effects and gastroparesis-like symptoms, screen for hypoglycemia if combined with sulfonylureas or insulin, and pair the medication with resistance training and 1.2–1.5 g/kg of protein to protect lean mass. Discuss with your prescriber.

Is bariatric surgery safe at my age?

It can be, in carefully selected older adults at experienced centers. The STAMPEDE trial (Schauer 2017, NEJM) and subsequent ASMBS 2020 older-adult guidance both support sleeve gastrectomy and Roux-en-Y gastric bypass in adults aged 65 and older when first-line treatments have failed and surgical risk is acceptable. Selection is the whole story: a comprehensive geriatric assessment, surgical risk scoring, evaluation of frailty and cognition, and a clear post-surgical plan for protein, calcium, vitamin D, B12, iron, and resistance training. Bone-mineral-density monitoring is essential. Older-adult outcomes are usually meaningful when selection is rigorous and supplementation and rehabilitation are taken seriously.

How much protein do I really need?

More than the old 0.8 g/kg RDA, which was set on younger weight-stable adults. The PROT-AGE consensus (Bauer 2013, Journal of the American Medical Directors Association) recommends 1.0 to 1.2 g/kg of body weight per day for healthy older adults and 1.2 to 1.5 g/kg per day during illness, recovery, or intentional weight loss. Distribution matters: older adults respond better to roughly 25 to 35 grams of protein per meal across 3 or 4 meals, because the per-meal threshold to stimulate muscle protein synthesis is higher with age (Volpi 2013, Journals of Gerontology). Breakfast is usually the lowest-protein meal of the day and the highest-leverage one to upgrade.

Why does my doctor keep telling me to lift weights?

Because resistance training is the single most muscle-protective thing you can do during weight loss after 65, and the LIFE trial (Villareal 2017, NEJM) made the case formally. In that randomized trial of adults with obesity aged 65 and older, the combination of diet plus aerobic and resistance training produced about 9 percent weight loss with measurably better function — and substantially better bone and lean-mass preservation — than diet alone. Walking is good for the heart and metabolism, but the mechanical signal it provides is too small to drive meaningful muscle adaptation. The LIFTMOR trial (Watson 2018, Journal of Bone and Mineral Research) further showed that heavy resistance training is safe and bone-protective in post-menopausal women with osteopenia or osteoporosis. Lifting is not optional after 65 — it is the protocol.

Weight Loss for Older Adults: BMI, Function, and the Honest Playbook

Quick answer

After age 65, the math of weight loss changes in four important ways: the BMI associated with the lowest mortality shifts upward to roughly 25–32 (Winter 2014, American Journal of Clinical Nutrition; Flegal 2013, JAMA), frailty and function become better predictors of outcomes than BMI alone (Fried 2001, Journals of Gerontology), lean mass and bone are lost faster during a deficit (Heymsfield 2014, Obesity Reviews; Kortebein 2007, JAMA), and polypharmacy interacts with intentional weight loss in ways middle-aged adults rarely face. The 2023 AGS / NIA position on geriatric obesity (Batsis 2023, Journal of the American Geriatrics Society) and the 2022 ESPEN-EASO sarcopenic obesity consensus (Donini 2022, Clinical Nutrition) both ask the same first question: not “how much should you weigh,” but “how well can you stand, walk, and lift.”

The honest playbook is function-first: target 0.25 to 0.5 percent of body weight per week, pair every intervention with progressive resistance training and 1.2–1.5 g/kg of protein, conduct a medication review at the start and every dose change, and re-measure grip strength and gait speed at 12 weeks. The LIFE trial (Villareal 2017, New England Journal of Medicine) showed this combination produces ~9 percent weight loss with measurably better function. GLP-1 medications and bariatric surgery work in carefully selected older adults — but only when paired with the same muscle-and-bone protection.

How weight loss in older adults differs from middle age

Four things change after 65. The cardiometabolic risk curve flattens, so the BMI that minimizes mortality drifts upward. Frailty replaces BMI as the dominant risk variable — grip strength and gait speed predict mortality better than the scale. Lean mass and bone are lost more easily, so the same deficit costs more muscle in a 75-year-old than in a 40-year-old. And polypharmacy creates interactions — diuretics, beta-blockers, insulin and sulfonylureas, mirtazapine, gabapentinoids — that change as weight comes down.

These shifts do not mean older adults should never lose weight. They mean the protocol that works at 40 is the wrong protocol at 75. The muscle and bone protection that is optional in middle age is mandatory after 65 — see the parallel detail in sarcopenia and weight loss, osteoporosis and weight loss, preserve muscle during weight loss, weight loss for women over 40, and the BMI calculator for the cut-points themselves.

Why older-adult weight loss is different — and where the BMI paradox actually comes from

The BMI U-curve shifts upward — but the “obesity paradox” does not mean weight loss is unsafe

Winter 2014’s meta-analysis in AJCN pooled cohort studies of adults 65 and older and found the U-shaped BMI–mortality curve shifted upward to a nadir of roughly 27–28. Flegal 2013’s JAMA meta of all-age data showed the same pattern: the lowest mortality in older subgroups sat in the 25–32 range. The paradox does not say weight gain is protective — it says BMI loses resolution in older populations because frailty, sarcopenia, and cardiometabolic disease all interact with body composition differently than they do at 40. Villareal 2017’s LIFE trial (NEJM) is the strongest direct evidence that intentional weight loss with resistance training improves function and mobility in older adults with obesity. See the BMI calculator for the underlying cut-points and metabolic syndrome and weight loss for the cardiometabolic context.

Sarcopenic obesity is the dominant phenotype to avoid

Donini 2022’s ESPEN-EASO consensus in Clinical Nutrition formally defined sarcopenic obesity as the combination of excess fat plus low muscle. The phenotype has worse outcomes than either obesity or sarcopenia alone — higher mortality, more falls and fractures, faster functional decline, and worse response to standard weight-loss interventions. Aggressive calorie deficits without resistance training worsen the sarcopenic side faster than they reduce the adipose side. See sarcopenia and weight loss for the diagnostic workflow and body fat percentage for the body-composition framing.

GLP-1 medications work in older adults — with adjustments for lean mass, hypoglycemia, gastroparesis-prone GI side effects, and CV outcomes

Wilding 2021’s STEP-1 trial in NEJM enrolled adults including those 65 and older, and the older subgroup achieved comparable weight loss to younger participants. Lincoff 2023’s SELECT trial in NEJM — also in NEJM — showed reduced major adverse cardiovascular events in adults with established cardiovascular disease, including substantial enrollment of adults over 65. The practical adjustments in older adults are real: slower dose titration, closer attention to gastrointestinal side effects and gastroparesis-like symptoms, hypoglycemia surveillance if combined with sulfonylureas or insulin, and tight pairing with resistance training and protein. See GLP-1 weight loss overview, Ozempic side effects, hypoglycemia and weight loss, and gastroparesis and weight loss.

Polypharmacy interacts with weight loss in ways middle age does not

Diuretics, beta-blockers, insulin and sulfonylureas, mirtazapine, gabapentinoids, anticholinergics, and SGLT2 inhibitors all interact with intentional weight loss. As body weight falls, doses that were appropriate at the starting weight can drift into a hypotension, hypoglycemia, or anticholinergic-burden zone. A medication review is not a separate consultation — it is part of the protocol at the start and at every dose change. See blood pressure and weight loss, diabetes and weight loss, and hypoglycemia and weight loss for the medication-specific detail.

How much each intervention helps in older adults

The table summarizes the size of effect commonly seen in older-adult trials. Ranges are deliberate — individual variation is large — but the ranking is durable.

5-step older-adult weight-loss protocol

1. Confirm intent and confirm there is something to lose — measure BMI, waist, grip strength, gait speed, and a 5-item frailty screen before any aggressive intervention. Fried 2001’s CHS frailty phenotype, Batsis 2023’s AGS / NIA position, and Donini 2022’s ESPEN-EASO consensus all argue the same point: intentional weight loss in already-frail older adults can worsen outcomes. The screening is not optional. See sarcopenia and weight loss for the SARC-F and grip-strength protocol and the BMI calculator for the body-composition baseline.
2. Set the deficit at 0.25–0.5% body weight per week, not 1% — slower preserves more muscle and bone. Heymsfield 2014’s Obesity Reviews meta showed the share of weight lost as lean mass grows with the size of the deficit. Schafer 2017’s Journal of Bone and Mineral Research data and Villareal 2017’s LIFE trial both showed faster losses cost more bone. See how long does it take to lose weight and how many calories to lose weight for the math.
3. Pair every weight-loss intervention with progressive resistance training 2–3× / week and 1.2–1.5 g/kg of protein distributed across 3–4 meals of 25–35 g. Watson 2018’s LIFTMOR trial showed heavy resistance training is safe and bone-protective in post-menopausal women with osteopenia. Bauer 2013’s PROT-AGE consensus and Volpi 2013’s Journals of Gerontology per-meal-threshold work both confirm older adults need higher per-meal protein. See strength training for weight loss, preserve muscle during weight loss, protein intake for weight loss, and high-protein snacks for weight loss.
4. Conduct a medication review at the start and at every dose change. Beta-blockers, sulfonylureas, insulin, mirtazapine, gabapentinoids, anticholinergics, and antihypertensives commonly need taper or hold as weight falls. Many older-adult dieting hospitalizations are avoidable medication-titration events — hypoglycemia, orthostatic hypotension, or falls. See diabetes and weight loss, blood pressure and weight loss, and hypoglycemia and weight loss.
5. Re-measure grip strength, gait speed, and frailty score at 12 weeks; if any has worsened, slow the deficit, intensify training, and revisit medication titration. Villareal 2017’s LIFE trial reframed the endpoint: the goal is function, not the scale. See non-scale victories and weight loss maintenance for the tracking that survives plateaus.

What treatments actually do

Special situations

The BMI “obesity paradox” — what it means and what it doesn’t

The U-shaped curve of BMI versus mortality is well replicated — Winter 2014’s AJCN meta and Flegal 2013’s JAMA meta both showed that in adults 65 and older the lowest-mortality BMI sits somewhere in the 25–32 range rather than the 22–25 range used for middle-aged adults. The honest interpretation: BMI loses resolution as a mortality predictor in older populations because sarcopenic obesity, frailty, and chronic illness change the meaning of body weight. The paradox does not justify weight gain. It justifies three protocol changes: switching the endpoint from “scale” to “function,” slowing the deficit, and pairing every intervention with resistance training. Villareal 2017’s LIFE trial showed that older adults with obesity who lost weight with paired diet and exercise improved function — the paradox is not an excuse to skip the work, it is an argument for doing the work differently. See the BMI calculator, body fat percentage, and sarcopenia and weight loss.

Frailty, fall risk, and the post-hospitalization window

Fried 2001’s Journals of Gerontology paper defined the operational frailty phenotype — slowness, weakness, weight loss, exhaustion, low activity — that predicts adverse outcomes better than BMI in older adults. Kortebein 2007’s JAMA bedrest experiment quantified the cost of inactivity: 10 days of bedrest in healthy older adults cost roughly 1 kg of leg lean mass. The first 90 days after a hospitalization is the highest-risk window for further functional loss, and it is the wrong time to start an aggressive weight-loss attempt. The right move in that window is calorie-adequate, protein-adequate, structured rehabilitation with progressive resistance training — not a deficit. See sarcopenia and weight loss and walking for weight loss for the staged return to load.

GLP-1 medications, bariatric surgery, and CV outcomes in adults 65+

The 2023 SELECT cardiovascular outcomes trial (Lincoff 2023, NEJM) showed semaglutide reduced major adverse cardiovascular events in adults with established cardiovascular disease and BMI ≥27 — with substantial enrollment of adults over 65. The 2017 STAMPEDE trial (Schauer 2017, NEJM) and the 2020 ASMBS older-adult position both support bariatric surgery in carefully selected older adults at experienced centers. Selection is the whole story in both cases. A formal geriatric assessment, surgical risk scoring, frailty and cognition evaluation, and a clear post-treatment plan for protein, calcium, vitamin D, B12, iron, and resistance training are the difference between a meaningful benefit and an avoidable complication. B12 deficiency is especially common in this age band — atrophic gastritis affects roughly 10 to 15 percent of adults over 60 and pernicious anemia about 2 percent — so annual screening is standard; see vitamin B12 deficiency and weight loss for the test, dose, and neurologic-red-flag protocol. See GLP-1 weight loss overview, bariatric surgery overview, and bariatric surgery vs GLP-1 medications for the procedure-by-procedure and drug-by-drug detail.

Red flags — when to see a doctor

• Unintentional weight loss above 5 percent in 6 months in an older adult — cancer, depression, hyperthyroidism, malabsorption, and dementia all need to be ruled out (Stajkovic 2011, CMAJ). Schedule a primary-care visit within 2 to 4 weeks.
• Recent fall or near-fall — frailty workup and physical-therapy referral are warranted within 2 weeks; falls are one of the largest modifiable contributors to disability after 65 (Fried 2001).
• New confusion or sleepiness on a diabetes or blood-pressure medication during weight loss — hypoglycemia or orthostatic hypotension; urgent medication review with your prescriber.
• Difficulty rising from a low chair or climbing one flight of stairs — sarcopenia screen with grip strength, chair-rise time, and gait speed; see sarcopenia and weight loss.
• Loss of appetite for more than 2 weeks — do not start a deficit; depression and gastrointestinal workup first.
• Persistent gastrointestinal symptoms on a GLP-1 in an older adult — gastroparesis screen and dose review; see gastroparesis and weight loss.

Sources